IP Library Granted Patent US 11,497,784
Granted Patent B2
US 11,497,784 · App. 17/158,666 · Granted Nov 15, 2022

Botanical extract for skin care

Inventors: Jatinder Rana (Grand Rapids, MI); Kylie Mitchell (Pennington, NJ)
Assignee: Innophos, LLC
A61K36/22A61K8/9789A61P17/18A61P29/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,497,784
App. No.
17/158,666
Granted
Nov 15, 2022
Kind
B2
Abstract

A botanical extract for use in skin care, wherein the botanical extract is at least an extract from the testa of the seed of Anacardium occidentale L.

Claims (13)

1. A method of inhibiting melanin production in a subject comprising

administering a composition comprising a botanical extract of the testa of the seed of Anacardium occidentale L.,

wherein the botanical extract has been standardized to a catechin content of about 15.0 w/w % or greater, based on total weight of the extract, and

wherein the botanical extract is present in the composition in a therapeutically effective amount of from about 1.0 μg/mL to about 2000.0 μg/mL.

2. The method according to claim 1 , wherein the composition is a cosmetic composition.

3. The method according to claim 2 , wherein the cosmetic composition is a skin whitening composition.

4. The method according to claim 1 , wherein the composition is effective in increasing the expression of antioxidant-related genes present in skin.

5. The method according to claim 1 , wherein the composition is effective in increasing MT1A expression in skin.

6. The method according to claim 1 , wherein the composition is effective in increasing NQO1 expression in skin.

7. The method according to claim 1 , wherein the composition is effective in increasing TXNRD1 expression in skin.

8. The method according to claim 1 , wherein the composition is effective in increasing the expression of anti-inflammatory-related genes present in skin.

9. The method according to claim 1 , wherein the composition is effective in increasing IL-1β expression in skin.

10. The method according to claim 1 , wherein the composition is a dietary supplement.

Assignments (1)
SECURITY INTEREST Recorded Jan 6, 2025
From: INNOPHOS, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 069749/0211 →
Continuity (3)
Division 16515097 · Jul 18, 2019
Provisional Application 62725441 · Aug 31, 2018
Related Publication 20210361729A1 · Nov 25, 2021